| 000 | 01728 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517044246.0 | ||
| 264 | 0 | _c20160324 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1471-2202 | ||
| 024 | 7 |
_a10.1186/s12868-015-0182-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeclerc, Jenna L | |
| 245 | 0 | 0 |
_aIntracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor. _h[electronic resource] |
| 260 |
_bBMC neuroscience _cAug 2015 |
||
| 300 |
_a48 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAstrocytes _xdrug effects |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCerebral Hemorrhage _xdrug therapy |
| 650 | 0 | 4 | _aCollagenases |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aGliosis _xdrug therapy |
| 650 | 0 | 4 |
_aHydrazines _xpharmacology |
| 650 | 0 | 4 |
_aIron _xmetabolism |
| 650 | 0 | 4 |
_aLeukocytes _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMicroglia _xdrug effects |
| 650 | 0 | 4 |
_aNeuroimmunomodulation _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aOxazepines _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Prostaglandin E, EP1 Subtype _xagonists |
| 650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
| 700 | 1 | _aAhmad, Abdullah S | |
| 700 | 1 | _aSingh, Nilendra | |
| 700 | 1 | _aSoshnik-Schierling, Luke | |
| 700 | 1 | _aGreene, Ellis | |
| 700 | 1 | _aDang, Alex | |
| 700 | 1 | _aDoré, Sylvain | |
| 773 | 0 |
_tBMC neuroscience _gvol. 16 _gp. 48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12868-015-0182-2 _zAvailable from publisher's website |
| 999 |
_c25129277 _d25129277 |
||